Clinical Trials Logo

Autism Spectrum Disorders clinical trials

View clinical trials related to Autism Spectrum Disorders.

Filter by:

NCT ID: NCT02940899 Completed - Clinical trials for Autism Spectrum Disorders

Syracuse University Fit Families Program: Autism

SUFFP
Start date: January 2015
Phase: N/A
Study type: Interventional

Syracuse University Fit Families is designed to increase the activity level and frequency of the children through modified activities using adapted equipment and, importantly, to increase the families' comfort level in having their children participate in a variety of physical activities, including team and individual sports.

NCT ID: NCT02940574 Completed - Clinical trials for Autism Spectrum Disorders

Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders

Start date: April 2015
Phase: Phase 4
Study type: Interventional

The current trial aims to explore the neural and behavioral effects of oxytocin in autism spectrum disorders (ASD). Oxytocin is a nonapeptide produced by the paraventricular and supraoptic nuclei of the hypothalamus and is known to play a pivotal role in a variety of complex social behaviors. Initial studies showed that intranasal administration of oxytocin can have a positive effect on social functioning in ASD. However, future studies are necessary to explore whether and how oxytocin effects neural processes in the brain underlying these behavioral improvements. This trial will not only measure behavioral enhancements, but will specifically focus on elucidating the associated neurophysiological changes by guiding the administration of oxytocin with regular neurophysiological assessments.

NCT ID: NCT02928068 Completed - Clinical trials for Autism Spectrum Disorders

Telehealth Coaching for Families of Children With Autism

Start date: April 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy of a 12 week telehealth intervention for families of children with autism spectrum disorders under the age of 6 years on child participation and parent efficacy.

NCT ID: NCT02903030 Completed - Anxiety Clinical Trials

Probiotics for Quality of Life in Autism Spectrum Disorders

Start date: August 2016
Phase: Early Phase 1
Study type: Interventional

A randomized pilot trial of a probiotic for quality of life in autism spectrum disorder (ASD), targeting gastrointestinal (GI) symptoms.

NCT ID: NCT02828332 Completed - Clinical trials for Autism Spectrum Disorders

Developmental Trajectories in ASD Until Adulthood: A 15 Years Follow-up Study

EpiTED
Start date: October 2012
Phase: N/A
Study type: Interventional

Epidemiological studies have shown that a wide range of outcome trajectories exist in ASD, but little is known about their determinant in a long-term perspective. The EpiTED cohort was set-up in order to understand the heterogeneity of developmental trajectories among children with a diagnosis of PDD and the role of clinical, biological and environmental factors in their adaptive outcome. It is one of the rare cohorts involving a long term prospective follow-up based on a large set of variables, and precise phenotypes of the entire autism spectrum.

NCT ID: NCT02797379 Completed - Anxiety Clinical Trials

The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders

MANAGE
Start date: September 1, 2016
Phase: N/A
Study type: Interventional

The purpose of this pilot intervention trial is to assess the efficacy of newly developed psychoeducation guides designed to manage anxiety in Autism Spectrum Disorder (ASD) by recruiting 30 participants with ASD and high levels of anxiety along with their parent/caregivers who both receive a version of the psychoeducation guide.

NCT ID: NCT02747459 Enrolling by invitation - Clinical trials for Autism Spectrum Disorders

Sensory Supported Swimming for Children With ASD

SSS
Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of Sensory Supported Swimming is to provide a sustainable, low cost recreational swim program for children with ASD. A secondary purpose is to train general recreation providers and swim instructors to meet the unique needs of children. Specific aims include both program development and research aims as described below. Specific Aims: 1. Provide more opportunities for families of children with ASD to access a recreational swim program at low cost. (program development) 2. Increase the capacity of swim instructors and general recreation providers working with children with ASD. (Research) 3. Increase physical activity for children with ASD in a way that is a good match for their individual sensory needs. (Research) 4. Increase safety among children with ASD in and around the water so they and their families can swim safely. (Research) 5. Transition swimmers with ASD from a learn-to-swim program to an inclusive swim team. (Program Development) Hypotheses 1. The Sensory Supported Swim Program will increase physical activity of children with ASD. 2. The Sensory Supported Swim Program will increase safety of children with ASD in and around the water. 3. The Sensory Supported Swim Program will increase the capacity of general recreation providers and swim instructors to serve children with ASD.

NCT ID: NCT02747056 Completed - Clinical trials for Autism Spectrum Disorders

Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency

TSASDI
Start date: June 2016
Phase: N/A
Study type: Interventional

The research aims at clarifying the impact of autism on personal identity in adulthood. Two studies will be made in order to compare adults with autistic spectrum disorders without intellectual deficiency and controls. In the first study (Study A), the investigators will ask subjects to tell autobiographical memories and to specify their characteristics by answering focused questions. In the second study (Study B), the investigators will ask subjects to say the self statements which define them. Then, subjects will have to tell and to specify the characteristics of the autobiographical memories linked to these self statements.

NCT ID: NCT02739321 Completed - Clinical trials for Autism Spectrum Disorders

Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD

Start date: May 2014
Phase: N/A
Study type: Interventional

The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To Sleep System™ in improving the sleep quality of children with Autism Spectrum Disorder (ASD). The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with auditory stimulation. For the present study, the primary objectives are as follows: * Study Aim 1 - To determine whether the use of the Sound To Sleep System™ in ASD-affected children with sleep disturbances is well tolerated as defined by group drop-out proportion due to issues with the mattress technology. The study will also explore the following objectives: - Study Aim 2 - To determine the efficacy of the Sound To Sleep System™ in improving sleep quality as measured by parent reported sleep quality in ASD-affected children with sleep disturbances. (Please note Study Aim 2 was changed from clinician-rated to parent-rated because we were not able to collect clinician-rated sleep quality information). - Study Aim 3 - To determine the tolerability of the Sound To Sleep System™ as defined by study drop-out due to any reason and caregiver ratings of ease of mattress technology use. - Study Aim 4 - To determine whether use of the mattress technology improves functioning as defined by secondary outcome measures.

NCT ID: NCT02700113 Completed - Clinical trials for Autism Spectrum Disorders

Investigating Phenotypic Profiles of Children and Adolescents With ASD

Phenotyping
Start date: November 2014
Phase:
Study type: Observational

The purpose of this study is to provide a detailed description of language and cognitive profiles found among children and adolescents diagnosed with autism spectrum disorders (ASD). Participants with ASD ages 4-17;12 years who have limited verbal skills will be given comprehensive behavioral assessments to collect data that will advance our understanding of language-related processes in individuals with ASD, the knowledge of which will help in designing future interventions for this population.